NCT07158190View on ClinicalTrials.gov

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Dengue
Interventions
BIOLOGICAL

Vaccine

Vaccine TAK003 administration

Trial Locations (1)

00168

Fondazione Policlinico Universtiario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT07158190 - Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda). | Biotech Hunter | Biotech Hunter